Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS registration process is proceeding well
2011-01-11

Ms Belinda Venter and her daughter, Stacey Venter, second year student in Consumer Sciences, registering online with the help of Donovan Nell, student assistant and currently a third-year student in Computer Sciences at the UFS.
- Photo: Leonie Bolleurs

The university implemented an online registrations process for senior students this year. “We are one of the first universities in the country where students can do the entire registration process online themselves. The advantage of this new turn in the registration process at the university is that students can register from the comfort of their homes or even from any place in the world,” says Prof. Niel Viljoen, Vice-Rector: Operations at the UFS.

Senior students who experienced problems during the registration programme from 1 November 2010 to 4 January 2011, have the opportunity to, within a programme, address these problems as from 5-12 January 2011. During this period UFS staff members will be available to assist students to register electronically.

However, senior students can still register online after 12 January until 28 January 2011.

The registration process of first-time entering first-year students is also proceeding well. Although a large number of applications for late registration have been received, it can be handled without difficulty.

First-year students are welcomed by Prof. Jonathan Jansen, Vice-Chancellor and Rector of the UFS, on Friday, 14 January and Saturday 15 January 2011 at 09:00 in the Callie Human Centre.

From 17- 21 January 2011, first-year students will receive academic advice at the Callie Human Centre, where after they will be referred for self-registration. These processes will take place according to the scheduled timetable, which appears in the Kovsie Guide. The Kovsie Guide was sent to first-year students, and is also available on the UFS webpage (www.ufs.ac.za/register2011).

The registration process for the Qwaqwa Campus is from 17-21 January 2011 for first-time entering first-year students and from 17-28 January 2011 for senior students.

According to personnel at the registration help desk, the following problems are reported the most frequently:

  • Forgotten or expired passwords: Students are requested to contact 051 401 2442 to report this problem.
  • Outstanding registration fees, which lead to the specific student’s account being blocked: Students are requested to contact 051 401 2806 for help in this regard.
  • If information regarding module codes is required, the relevant faculty can be visited for academic advice.


Classes on the Main and Qwaqwa Campuses will start on Monday, 24 January 2011.

 

Media Release
11 January 2011
Issued by: Lacea Loader
Director: Strategic Communication (actg)
Tel: 051  401 2584
Cell: 083 645 2454
E-mail: news@ufs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept